Publications
328
Citations
22,893
Est. group size
~1
Recurring co-author estimate
Active years
30
Publishing since 1997
Typically publishes in teams of ~15 · 6% small-team papers (≤3 authors) · across 46 venues
- Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy
Haematologica · 2026
- High programmed death-ligand 1 expression is associated with a shorter progression free survival in ALK-rearranged lung cancer patients treated with first line tyrosine kinase inhibitors
SSRN Electronic Journal · 2026
- All for One and One for All? The Role of RNA-Based Next-Generation Sequencing in the Molecular Profiling of Tumors
Clinical Chemistry · 2026
- 970 Endometrial Carcinomas Are Enriched for Acetylsalicylic Acid (ASA)-Associated PI3K Pathway Mutations
Laboratory Investigation · 2026
- Longitudinal, Retrospective Use of a Circulating Tumor DNA Methylation Signature Successfully Captures Small Cell Evolution in a Patient With Metastatic EGFR-Mutant Non–Small Cell Lung Cancer
JCO Precision Oncology · 2026
- Copy Number-low/TP53-mutated Endometrial Cancer With Wild-type p53 Immunoexpression: Implications for Risk Stratification and Management When Using Next-generation Sequencing for Molecular Classification
Modern Pathology · 2026
- Recommended Terms and Definitions From the 2025 NCCN Biomarkers Resource Committee
Journal of the National Comprehensive Cancer Network · 2026
- High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase Inhibitors
Clinical Lung Cancer · 2026
- Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis
Lung Cancer · 2025
- Novel PLEC-EML4-ALK Double Fusion Underlying Crizotinib Resistance in a Metastatic Inflammatory Myofibroblastic Tumor: A Case Report
JTO Clinical and Research Reports · 2025
- A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial
Clinical Cancer Research · 2025
- 40: Mixing ploidies and assays: A case report of perinatal diagnosis and outcome for diploid/triploid mixoploidy
Genetics in Medicine Open · 2025
- 983 ARID1A Immunohistochemistry (IHC) Shows Low Sensitivity for ARID1A Mutation by Next Generation Sequencing (NGS) in Endometrial Carcinomas
Laboratory Investigation · 2025
- Characteristics of Short-Term Survivors With ALK or ROS1-Altered Metastatic NSCLC
JTO Clinical and Research Reports · 2025
- Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study
Journal of Clinical Oncology · 2024
- Journal of Thoracic Oncology×28
- Journal of the National Comprehensive Cancer Network×14
- Archives of Pathology & Laboratory Medicine×11
- Journal of Clinical Oncology×10
- Journal of Molecular Diagnostics×9
- Samantha L. Savitch
Medicine · University of Michigan
- Ying Yang
Medicine · University of Michigan
- Nithya Ramnath
Medicine · University of Michigan
- Gregory P. Kalemkerian
Medicine · University of Michigan
- Pan Tong
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile